World Health Organization: Global Tuberculosis Report. Book Global Tuberculosis Report. 2012, City: World Health Organization
Havlir DV, Getahun H, Sanne I, Nunn P: Opportunities and challenges for HIV care in overlapping HIV and TB epidemics. JAMA. 2008, 300: 423-430.
Oeltmann JE, Kammerer JS, Pevzner ES, Moonan PK: Tuberculosis and substance abuse in the United States, 1997–2006. Arch Intern Med. 2009, 169: 189-197.
Kamboj M, Sepkowitz KA: The risk of tuberculosis in patients with cancer. Clin Infect Dis. 2006, 42: 1592-1595.
Hussein MM, Mooij JM, Roujouleh H: Tuberculosis and chronic renal disease. Semin Dial. 2003, 16: 38-44.
Ludvigsson JF, Wahlstrom J, Grunewald J, Ekbom A, Montgomery SM: Coeliac disease and risk of tuberculosis: a population based cohort study. Thorax. 2007, 62: 23-28.
Jick SS, Lieberman ES, Rahman MU, Choi HK: Glucocorticoid use, other associated factors, and the risk of tuberculosis. Arthritis Rheum. 2006, 55: 19-26.
Rabe KF, Hurd S, Anzueto A, Barnes PJ, Buist SA, Calverley P, Fukuchi Y, Jenkins C, Rodriguez-Roisin R, van Weel C, Zielinski J: Global strategy for the diagnosis, management, and prevention of chronic obstructive pulmonary disease: GOLD executive summary. Am J Respir Crit Care Med. 2007, 176: 532-555.
Buist AS, McBurnie MA, Vollmer WM, Gillespie S, Burney P, Mannino DM, Menezes AM, Sullivan SD, Lee TA, Weiss KB: International variation in the prevalence of COPD (the BOLD Study): a population-based prevalence study. Lancet. 2007, 370: 741-750.
Schirnhofer L, Lamprecht B, Vollmer WM, Allison MJ, Studnicka M, Jensen RL, Buist AS: COPD prevalence in Salzburg, Austria: results from the Burden of Obstructive Lung Disease (BOLD) Study. Chest. 2007, 131: 29-36.
Halbert RJ, Natoli JL, Gano A, Badamgarav E, Buist AS, Mannino DM: Global burden of COPD: systematic review and meta-analysis. Eur Respir J. 2006, 28: 523-532.
Menezes AM, Perez-Padilla R, Hallal PC, Jardim JR, Muino A, Lopez MV, Valdivia G, Pertuze J, Montes de Oca M, Talamo C: Worldwide burden of COPD in high- and low-income countries. Part II. Burden of chronic obstructive lung disease in Latin America: the PLATINO study. Int J Tuberc Lung Dis. 2008, 12: 709-712.
Ko FW, Hui DS, Lai CK: Worldwide burden of COPD in high- and low-income countries. Part III. Asia-Pacific studies. Int J Tuberc Lung Dis. 2008, 12: 713-717.
Wedzicha JA, Calverley PM, Seemungal TA, Hagan G, Ansari Z, Stockley RA: The prevention of chronic obstructive pulmonary disease exacerbations by salmeterol/fluticasone propionate or tiotropium bromide. Am J Respir Crit Care Med. 2008, 177: 19-26.
Calverley PM, Anderson JA, Celli B, Ferguson GT, Jenkins C, Jones PW, Yates JC, Vestbo J: Salmeterol and fluticasone propionate and survival in chronic obstructive pulmonary disease. N Eng J Med. 2007, 356: 775-789.
Shu CC, Wu HD, Yu MC, Wang JT, Lee CH, Wang HC, Wang JY, Lee LN, Yu CJ, Yang PC, Taiwan Anti-Mycobacteria Investigation G: Use of high-dose inhaled corticosteroids is associated with pulmonary tuberculosis in patients with chronic obstructive pulmonary disease. Medicine. 2010, 89: 53-61.
Brassard P, Suissa S, Kezouh A, Ernst P: Inhaled corticosteroids and risk of tuberculosis in patients with respiratory diseases. Am J Respir Crit Care Med. 2011, 183: 675-678.
The National Health Insurance Statistics. http://www.nhi.gov.tw/English/webdata/webdata.aspx?menu=11&menu_id=296&webdata_id=1942&WD_ID=296]
Lee CH, Lee MC, Lin HH, Shu CC, Wang JY, Lee LN, Chao KM: Pulmonary tuberculosis and delay in anti-tuberculous treatment are important risk factors for chronic obstructive pulmonary disease. PLoS One. 2012, 7: e37978-
Taiwan Guidelines for TB Diagnosis and Treatment. Edited by: Luh K-T. 2011, Taipei, Taiwan: Centers for Disease Control, R.O.C. (Taiwan), 4
National Committee for Clinical Laboratory Standards (NCCLS) Antimycobacterial susceptibility testing for Mycobacterium tuberculosis: tentative standard. NCCLS document M24-T. 1995, Villanova, PA: NCCLS
WHO Collaborating Centre for Drug Statistics Methodology: Guidelines for ATC classification and DDD assignment. 2011, 14
Bateman ED, Hurd SS, Barnes PJ, Bousquet J, Drazen JM, FitzGerald M, Gibson P, Ohta K, O'Byrne P, Pedersen SE: Global strategy for asthma management and prevention: GINA executive summary. Eur Respir J. 2008, 31: 143-178.
COPD prevalence in 12 Asia-Pacific countries and regions: projections based on the COPD prevalence estimation model. Respirology. 2003, 8: 192-198.
Wu CF, Feng NH, Chong IW, Wu KY, Lee CH, Hwang JJ, Huang CT, Lee CY, Chou ST, Christiani DC, Wu MT: Second-hand smoke and chronic bronchitis in Taiwanese women: a health-care based study. BMC Public Health. 2010, 10: 44-
Calverley PM, Walker P: Chronic obstructive pulmonary disease. Lancet. 2003, 362: 1053-1061.
Di Stefano A, Capelli A, Lusuardi M, Balbo P, Vecchio C, Maestrelli P, Mapp CE, Fabbri LM, Donner CF, Saetta M: Severity of airflow limitation is associated with severity of airway inflammation in smokers. Am J Respir Crit Care Med. 1998, 158: 1277-1285.
Calverley P, Pauwels R, Vestbo J, Jones P, Pride N, Gulsvik A, Anderson J, Maden C: Combined salmeterol and fluticasone in the treatment of chronic obstructive pulmonary disease: a randomised controlled trial. Lancet. 2003, 361: 449-456.
Wang JJ, Rochtchina E, Tan AG, Cumming RG, Leeder SR, Mitchell P: Use of inhaled and oral corticosteroids and the long-term risk of cataract. Ophthalmology. 2009, 116: 652-657.
Lipworth BJ: Systemic adverse effects of inhaled corticosteroid therapy: A systematic review and meta-analysis. Arch Intern Med. 1999, 159: 941-955.
Israel E, Banerjee TR, Fitzmaurice GM, Kotlov TV, LaHive K, LeBoff MS: Effects of inhaled glucocorticoids on bone density in premenopausal women. N Eng J Med. 2001, 345: 941-947.
Schleimer RP: Glucocorticoids suppress inflammation but spare innate immune responses in airway epithelium. Proc Am Thorac Soc. 2004, 1: 222-230.
Wang PH, Wang HC, Cheng PW, Cheng SL, Tsai CC: Hoarseness in asthmatic patients: the side effect of inhaled steroid or not?. J Asthma. 2007, 44: 823-826.
Davies L, Angus RM, Calverley PM: Oral corticosteroids in patients admitted to hospital with exacerbations of chronic obstructive pulmonary disease: a prospective randomised controlled trial. Lancet. 1999, 354: 456-460.
Niewoehner DE, Erbland ML, Deupree RH, Collins D, Gross NJ, Light RW, Anderson P, Morgan NA: Effect of systemic glucocorticoids on exacerbations of chronic obstructive pulmonary disease, Department of Veterans Affairs Cooperative Study Group. N Eng J Med. 1999, 340: 1941-1947.
Maltais F, Ostinelli J, Bourbeau J, Tonnel AB, Jacquemet N, Haddon J, Rouleau M, Boukhana M, Martinot JB, Duroux P: Comparison of nebulized budesonide and oral prednisolone with placebo in the treatment of acute exacerbations of chronic obstructive pulmonary disease: a randomized controlled trial. Am J Respir Crit Care Med. 2002, 165: 698-703.
Gunen H, Hacievliyagil SS, Yetkin O, Gulbas G, Mutlu LC, In E: The role of nebulised budesonide in the treatment of exacerbations of COPD. Eur Respir J. 2007, 29: 660-667.
Bock NN, Sotir MJ, Parrott PL, Blumberg HM: Nosocomial tuberculosis exposure in an outpatient setting: evaluation of patients exposed to healthcare providers with tuberculosis. Infect Control Hosp Epidemiol. 1999, 20: 421-425.
Joshi R, Reingold AL, Menzies D, Pai M: Tuberculosis among health-care workers in low- and middle-income countries: a systematic review. PLoS Med. 2006, 3: e494-
Baker MA, Lin HH, Chang HY, Murray MB: The risk of tuberculosis disease among persons with diabetes mellitus: a prospective cohort study. Clin Infect Dis. 2012, 54: 818-825.
Baijal R, Praveenkumar HR, Amarapurkar DN, Nagaraj K, Jain M: Prevalence of tuberculosis in patients with cirrhosis of liver in western India. Trop Doct. 2010, 40: 163-164.
Lin HH, Ezzati M, Chang HY, Murray M: Association between tobacco smoking and active tuberculosis in Taiwan: prospective cohort study. Am J Respir Crit Care Med. 2009, 180: 475-480.
Salvi SS, Barnes PJ: Chronic obstructive pulmonary disease in non-smokers. Lancet. 2009, 374: 733-743.
Ehrlich RI, White N, Norman R, Laubscher R, Steyn K, Lombard C, Bradshaw D: Predictors of chronic bronchitis in South African adults. Int J Tuberc Lung Dis. 2004, 8: 369-376.